Healthcare provider profile · identity verified

Michael E Kogut, DO

Internal Medicine · CALEDONIA, MI · NPI 1649619925

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	683	204
Lisinopril	Lisinopril	420	118
Omeprazole	Omeprazole	372	116
Amlodipine Besylate	Amlodipine Besylate	330	89
Levothyroxine Sodium	Levothyroxine Sodium	311	84
Metformin Hcl	Metformin Hcl	245	66
Tamsulosin Hcl	Tamsulosin Hcl	230	77
Losartan Potassium	Losartan Potassium	196	60
Rosuvastatin Calcium	Rosuvastatin Calcium	192	62
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	183	39
Hydrochlorothiazide	Hydrochlorothiazide	180	57
Prednisone	Prednisone	180	116
Gabapentin	Gabapentin	164	41
Pravastatin Sodium	Pravastatin Sodium	153	40
Metoprolol Succinate	Metoprolol Succinate	149	51
Fluticasone Propionate	Fluticasone Propionate	135	68
Pregabalin	Pregabalin	133	31
Simvastatin	Simvastatin	129	37
Pantoprazole Sodium	Pantoprazole Sodium	127	38
Alprazolam	Alprazolam	120	26
Albuterol Sulfate Hfa	Albuterol Sulfate	116	51
Sertraline Hcl	Sertraline Hcl	113	35
Bupropion Xl	Bupropion Hcl	112	31
Duloxetine Hcl	Duloxetine Hcl	110	32
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	109	40
Escitalopram Oxalate	Escitalopram Oxalate	108	26
Trazodone Hcl	Trazodone Hcl	106	39
Potassium Chloride	Potassium Chloride	105	33
Furosemide	Furosemide	103	34
Montelukast Sodium	Montelukast Sodium	102	34
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	96	25
Carvedilol	Carvedilol	93	26
Jardiance	Empagliflozin	92	17
Januvia	Sitagliptin Phosphate	87	18
Tramadol Hcl	Tramadol Hcl	82	24
Azithromycin	Azithromycin	75	65
Allopurinol	Allopurinol	72	22
Cephalexin	Cephalexin	71	36
Eliquis	Apixaban	70	21
Fluoxetine Hcl	Fluoxetine Hcl	70	17
Finasteride	Finasteride	69	20
Pioglitazone Hcl	Pioglitazone Hcl	65	20
Meloxicam	Meloxicam	63	17
Celecoxib	Celecoxib	60	18
Famotidine	Famotidine	60	18
Propranolol Hcl Er	Propranolol Hcl	60	19
Metformin Hcl Er	Metformin Hcl	59	18
Atenolol	Atenolol	57	13
Trulicity	Dulaglutide	56	11
Dicyclomine Hcl	Dicyclomine Hcl	54	22
Donepezil Hcl	Donepezil Hcl	54	suppressed
Xarelto	Rivaroxaban	54	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	17
Clopidogrel	Clopidogrel Bisulfate	52	16
Zolpidem Tartrate	Zolpidem Tartrate	45	suppressed
Clonazepam	Clonazepam	44	11
Ropinirole Hcl	Ropinirole Hcl	43	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	11
Metoprolol Tartrate	Metoprolol Tartrate	42	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	41	suppressed
Buspirone Hcl	Buspirone Hcl	40	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	40	11
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	40	suppressed
Ibuprofen	Ibuprofen	38	24
Ezetimibe	Ezetimibe	37	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	34	26
Novolog Flexpen	Insulin Aspart	33	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	32	11
Methocarbamol	Methocarbamol	32	14
Lovastatin	Lovastatin	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	25
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Symbicort	Budesonide/Formoterol Fumarate	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Farxiga	Dapagliflozin Propanediol	26	suppressed
Humalog Kwikpen U-100	Insulin Lispro	26	suppressed
Lorazepam	Lorazepam	26	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Glipizide Er	Glipizide	25	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	25	suppressed
Prazosin Hcl	Prazosin Hcl	25	suppressed
Spironolactone	Spironolactone	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	23	15
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	22	19
Klor-Con M20	Potassium Chloride	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Valsartan	Valsartan	19	suppressed
Diazepam	Diazepam	18	suppressed
Methylprednisolone	Methylprednisolone	18	17
Ramipril	Ramipril	18	suppressed
Testosterone Cypionate	Testosterone Cypionate	18	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Glipizide	Glipizide	17	suppressed
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Folic Acid	Folic Acid	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Colchicine	Colchicine	15	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Tradjenta	Linagliptin	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	13	suppressed
Haloperidol	Haloperidol	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Bydureon Bcise	Exenatide Microspheres	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Naproxen	Naproxen	12	suppressed
Ozempic	Semaglutide	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error